Regarding Parkinson’s disease, AAV-mediated overexpression of human alpha-synuclein in rodents recapitulates key Parkinson’s features, serving as a valuable model for development and evaluation of therapeutic strategies. This evidence concerns the gene SNCA and Parkinson disease.